English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
9 天
Acura制药公司与AD Pharma修订协议,面临财务挑战
伊利诺伊州PALATINE讯 — Acura制药公司(OTC Market: ACUR)是一家专注于开发防滥用药物的微型制药公司,市值仅为USD 0.05百万。根据最新的SEC文件显示,该公司已与Abuse Deterrent Pharma, LLC(AD Pharma)达成修订协议。尽管该公司股票在过去六个月下跌近79%,但年初至今仍上涨300%。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
To host Golden Globes
Asks SCOTUS to intervene
200% tariff on EU alcohol?
Plane engine catches fire
Trump Tower protest
Out as creative director
CDC nomination withdrawn
Ordered to reinstate workers
Won't run for Senate in MI
Says he supports ceasefire
States sue to block layoffs
Acne treatments recalled
Texas Tech closes campus
Exits bankruptcy protection
Teixeira pleads guilty
Legendary sportswriter dies
UN report accuses Israel
Smishing scam warning
Police charge stepmother
Weekly jobless claims fall
Ditch new stadium deal
Top FDA lawyer resigns
IRS demotes chief counsel
Won't block GOP bill
Swatting call about gunman
Khalil sues Columbia
Urges US to move nukes
To test Community Notes
$3B deal to extend rights
US influencer sparks outrage
Hits correction territory
FDA, NIH nominees advance
反馈